Access

Correspondence

Nature Genetics 40, 1035–1036 (1 September 2008) | doi:10.1038/ng0908-1035

Reply to |[ldquo]|Variation in KLK genes, prostate-specific antigen and risk of prostate cancer|[rdquo]|

Rosalind Eeles , Graham Giles , David Neal , Kenneth Muir & Douglas F Easton

Eeles et al. reply: We recently conducted a genome-wide association study (GWAS) using data from 1,854 individuals with clinically detected (not PSA screened) prostate cancer diagnosed at <60 years or with a family history of the disease, and 1,894 population-screened controls with a prostate-specific antigen (PSA) of <0.5ng/ml (ref.